Skip to main content
. 2020 Jul 6;15(5):653–665. doi: 10.5009/gnl20019

Table 1.

Summary of Helicobacter pylori Infection Prevalence, Virulence Factor and Antibiotic Resistance in Indonesia

Characteristic Bali Java Kalimantan Papua Sumatera Sulawesi Timor Total Reference
H. pylori prevalence 7 (11.5) 17 (4.0) 6 (6.7) 9 (42.9) 26 (19.8) 13 (14.9) 14 (40.0) 88 (10.4) 23
Subjects (number) 61 424 90 21 131 87 35 849
Virulence factor 23
cagA positive 6 (100) 11 ( 78.6) 5 (100) 7 (100) 18 (100) 13 (100) 13 (92.9) 73 (94.8)
cagA type
East Asian-type 3 (50.0) 10 (71.4) 2 (40.0) 1 (14.3) 18 (100) 9 (69.2) 6 (42.9) 49 (67.1)
Western-type 3 (50.0) 1 (7.1) 3 (60.0) 0 0 4 (30.8) 7 (50.0) 18 (24.7)
ABB-type 0 0 0 6 (85.7) 0 0 0 6 (8.2)
vacA s1/m1 6 (100.0) 7 (50.0) 5 (100) 7 (100) 9 (50.0) 6 (46.2) 12 (85.7) 52 (67.5)
oipA “on” 6 (100.0) 12 (85.7) 4 (80.0) 6 (85.7) 18 (100) 12 (92.3) 14 (100) 72 (93.5)
dupA negative 6 (100.0) 11 (78.6) 3 (60.0) 7 (100) 17 (94.4) 13 (100) 8 (57.1) 65 (84.4)
Strain (number) 6 14 5 7 18 13 14 77
Antibiotic resistant rate 23
Clarothromycin 1 (16.7) 3 (21.4) 0 1 (14.3) 1 (7.7) 1 (5.6) 0 7 (9.1)
Amoxicillin 0 0 0 1 (14.3) 1 (7.7) 1 (5.6) 1 (7.1) 4 (5.2)
Metronidazole 2 (33.3) 7 (50.0) 1 (20.0) 3 (42.9) 4 (30.8) 16 (88.9) 3 (21.4) 36 (46.7)
Levofloxacin 1 (16.6) 7 (50.0) 1 (20.0) 2 (28.6) 2 (15.4) 8 (44.4) 3 (21.4) 24 (31.2)
Tetracycline 0 2 (14.3) 0 0 0 0 0 2 (2.6)
Strain (number) 6 14 5 7 18 13 14 77
Furazolidone 0 0 0 0 0 0 0 0 24
Sitafloxacin 0 0 0 0 0 0 0 0
Garenoxacin 0 2 (15.4) 0 0 0 3 (16.7) 0 5 (6.5)
Rifaximin 3 (50.0) 4 (30.7) 3 (60.0) 2 (28.5) 6 (46.1) 3 (16.7) 6 (42.8) 27 (35.5)
Rifabutin 0 0 0 0 0 0 0 0
Strain (number) 6 13 5 7 18 13 14 76

Data are presented as number (%).